An interventional study of Geriatric assessment in the 7 days following ICU discharge. and No geriatric assessment in the 7 days following ICU discharge. in Critical Illness, Geriatric Assessment and Older People, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2025-04-29.
Sponsored by University Hospital, Strasbourg, France · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Frailty with a site in France — 23 open to participants now, 25 under way, none of them phase 3. Frailty · France.
Among the 59 studies in Frailty with a site in France, this one is the 17th largest by planned enrollment of the 27 interventional ones that give a count, is one of 6 that started in 2024, is one of 27 with no phase, reaches primary completion later than 8 of the 24 other live ones, and was the 41st registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →23 of the 59 studies in Frailty with a site in France are open now. Recruiting first, the newest first:
Fondation Hôpital Saint-Joseph · Sites in France
Ages 18+
University Hospital, Grenoble · Sites in France
Ages 70+
University Hospital, Toulouse · Sites in France
Ages 70+
Centre Hospitalier Universitaire de Saint Etienne · Sites in France
Ages 65+
University Hospital, Bordeaux · Sites in France
Ages 75+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 75 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 6 started in 2024.
This study's planned enrollment of 70 is below the median of 83 across 772 interventional studies indexed under Frailty.
Median enrollment 106 across the 27 interventional studies, 200 across the 32 observational. Of the 29 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 59 have an industry lead sponsor. The 10 most frequent:
University Hospital, Strasbourg, France is the lead sponsor of 1,000 studies on the registry; 359 are open to participants now.
University Hospital, Strasbourg, France has 1 study filed under Frailty — fewer than ten, so there is no comparison to draw.
7 of the studies in Frailty with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06247189University Hospital, ToulouseICOPE Program Feasibility in the Management of Myeloma Patients | 2026-12-03 |
| NCT06513130University Hospital, Strasbourg, FranceGeriatric Assessment at Discharge From the Intensive Care Unit in Patients Aged 75 Years and Older: a Feasibility Study | 2027-01-02 |
| NCT06887075University Hospital, BordeauxSystemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation | 2027-02-15 |
| NCT07348081Fondation Hôpital Saint-JosephReal World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department. | 2027-03-12 |
| NCT07379099MSPU de Pins-JustaretImplementation of the Personalized Care Plan (PCP) Proposed at the End of Step 2 of the ICOPE Program | 2027-06-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 59 studies in Frailty with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The number of patients aged over 75 continues to grow, and, according to INSEE, will represent almost 10% of the French population in 2021, an increase of 2.4 points since 2000. This demographic change is also observed in the intensive care units, where admitted patients aged over 80 represent now up to 10-20% of critical care admissions, depending on the facility.
The admission of these patients remains controversial, with questions about the benefit to elderly patients, both in terms of in-hospital and distant survival, as well as induced morbidity or subsequent quality of life: functional status is impaired in up to two-thirds of survivors.
The challenge of identifying the patients most able to withstand a stay is a major one. Indeed, a stay in intensive care represents a major stress for the organism, due to the acute condition associated with one or more organ failure(s). Bed rest, immobilization and the use of drugs are responsible for formidable complications in the elderly: muscle-wasting, loss of adaptation to physical effort, loss of autonomy, delirium and agitation, all of which have their own long-term impact.
While many studies have looked at the prognostic factors on admission of these patients, and the selection of the patient with the greatest probability of surviving the intensive care unit (ICU), improving the outcome of patients who survive to the ICU stay remains a little-investigated subject. However, the impact of physical and psychological disturbances induced by these patients' stay in intensive care is major, and their detection and management could be elements of interest in improving the care of this population. However, the feasibility of carrying out such an assessment immediately after an ICU stay has yet to be evaluated. The aim of this study would be to evaluate the feasibility of a geriatric assessment at the end of the ICU stay (or within 7 days of discharge) and at 6 months. This study is a prospective, randomized, single-center, open-label interventional study.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
This study's planned enrollment of 70 is below the median of 83 across 772 interventional studies indexed under Frailty.
Browse Frailty studies →University Hospital, Strasbourg, France is the lead sponsor of 1,000 studies on the registry; 359 are open to participants now.
Compared within Frailty, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Critical Illness. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will be assessed by a geriatric physician, in a global (clinical, physical, psyochological and social) approach at the end of the ICU stay or in the 7 days following. In addition to the first visit in the group "without geriatric assessment", will be collected: * Living conditions (home, proxy, home support) * Quality of life (SF-36) * Covi test and 4-item Geriatric Depression Scale * Katz-ADL and IADL * History of fall, mobility assessment * Nutritional status (BMI, albuminemia, Mini Nutritionnal Assesment) * Cognitive assessment (Mini-mental State Examination) The visit at month 6 will be the same in both groups
Other: Geriatric assessment in the 7 days following ICU discharge.
At the end of the ICU stay or in the 7 days following, will be collect: * Medical and surgical history, Charlson comorbidity index, * Living place * Regular treatment (number and class) * ICU trajectory: ICU length of stay, reason for ICU admission, severity scores (SOFA and SAPS 2 score), organ supports requirement and duration * Limitation of life-sustaining therapy decision At 6 month after ICU discharge, patients will be evaluated during a post-ICU consultation, where will be recorded: * Living conditions (home, proxy, home support) * Quality of life (SF-36) * Covi test and 4-item Geriatric Depression Scale * Katz-ADL and IADL * History of fall, mobility assessment * Nutritional status (BMI, albuminemia, Mini Nutritionnal Assesment) * Cognitive assessment (Mini-mental State Examination) * Regular treatment (number and class) * Hospitalizations between ICU discharge and M6 * Additional comorbidity * Family burden assessment (mini-Zarit)
Other: No geriatric assessment in the 7 days following ICU discharge.
ICU survivors will be assessed by a geriatric physician, in a global (clinical, physical, psyochological and social) approach at the end of the ICU stay or in the 7 days following ICU discharge.
No geriatric assessment in the 7 days following ICU discharge.
Rate of patients for whom a geriatric assessment is carried out between the end of their stay in intensive care and 7 days after discharge.
Time frame: At 6 Month after ICU discharge
Rate of patients for whom consultation at M6 is carried out.
Time frame: At 6 Month after ICU discharge
Frailty, assessed using the Clinical Frailty Scale
Time frame: At 6 Month after ICU discharge
Total hospital length of stay
Time frame: At 6 Month after ICU discharge
Number of hospitalization
Time frame: At 6 Month after ICU discharge
Regular treatment modifications
collection of current treatments on admission to intensive care, on discharge from intensive care and hospitalization, and at M6 (prescription)
Time frame: At 6 Month after ICU discharge
Modification of place of living
location (single-family dwelling, retirement home, etc.)
Time frame: At 6 Month after ICU discharge
Evolution of the quality of life assessed by the SF-36 questionnary
For the interventional arm
Time frame: At 6 Month after ICU discharge
Evolution of the psychological behaviours through the mini Geriatric depression score evolution and the Covi test evolution for the anxiety component.
For the interventional arm
Time frame: At 6 Month after ICU discharge
Evolution of the psychological behaviours through the Covi test evolution for the anxiety component.
For the interventional arm
Time frame: At 6 Month after ICU discharge
Evolution of the Katz-ADL score between initial assessment and month 6
For the interventional arm For the control arm,
Time frame: At 6 Month after ICU discharge
Evolution of the IADL score between initial assessment and month 6
For the interventional arm For the control arm,
Time frame: At 6 Month after ICU discharge
Evolution of the locomotor abilities
Time frame: At 6 Month after ICU discharge
Evolution of cognition evaluation: mini Mental State Examination
Time frame: At 6 Month after ICU discharge
At M6: main organ function assessment
Time frame: At 6 Month after ICU discharge
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Jan 2027, 26 months after the start.
Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 26 months is above that.
Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →